isophosphamide mustard has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amedio, J; Jones, B; Komarnitsky, P; Miller, GT; Wallner, BP | 1 |
| Corbett, TH; Dykes, DJ; Struck, RF; Suling, WJ; Trader, MW | 1 |
2 other study(ies) available for isophosphamide mustard and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Ifosfamide; Injections, Intravenous; Leukemia, Experimental; Lysine; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Phosphoramide Mustards; Rats; Rats, Sprague-Dawley; Taxoids; Xenograft Model Antitumor Assays | 2012 |
Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Colonic Neoplasms; Cyclophosphamide; Female; Ifosfamide; Leukemia, Experimental; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasms, Experimental; Phosphoramide Mustards; Rats; Sarcoma, Yoshida | 1983 |